Anti-dyslipidaemics Flashcards

1
Q

Explain this picture?

A

Cholesterol is synthesised from acetyl coA.

Inhibiting HMG coA reductase could help prevent high cholesterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which lipoprotein is protective? Which are atherlerogenic?

A

HDL=good.

LDL and IDL=bad.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which apoproteins are in which lipoproteins?

A

ApoA and ApoB.

LDL and VLDL are associated with ApoB100 proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What role does HDL have?

A
  • Delivers cholesterol esters to livse and LDLs in plasma for peripheral delivery.
  • Also plays a vital role in scavenging excess used cholesterol from peripheral tissues.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 2 ways in which cells can obtain cholesterol?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the process of LDL uptake from the plasma into cells?

What happens to the receptors after uptake?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the downstream effects (in the photo)?

A

Raised intracellular cholesterol has 3 effects:

1) Decreased activity of HMG CoA reductase.
2) activates acetyl coA:cholesterolacyltransferase (ACAT) to esterify free cholesterol into cholesterol ester that can be stored within the cell.
3) Inhibits the gene encoding for the LDL receptor, and therefore decreases further uptake of LDL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does an increase in plasma cholesterol put you at risk of?

A

Atherosclerosis and therefore CHD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LDL makes it to the _____ of the _______ arteries.

This is then taken up by _________ and this turns them into _______ cells.

This then leads to cell __________ and matrix _________.

A

Intima of the elastic arteries.

Macrophages and turns them to foam cells.

cell growth and matrix degradation.

(the macrophages release even more cytokines which attract them to the intima).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Main causes of high cholesterol?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most effective pharmacological intervention for dyslipidemia?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do statins work?

A

They inhibit HMG-CoA reductase action. This means that hepatic de novo synthesis of cholesterol is inhibited. This increases the cells LDL-R (increase in LDL gene expression) removing LDL from circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is a statin considered to have pleiotropic effects?

A

The decrease in hepatocyte cholesterol causes a lot of good downstream effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the statin which we need to know?

A

Atorvastatin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is atorvastatin removed from the body? (what major enzyme degrades it?)

What is the half life of atorvastatin and its active metabolites?

_____ impairment increases atorvastatin retention, _____ impairment has no major impact.

A

CYP3A4.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the example of the cholesterol uptake inhibitor and how does it work?

A

Ezetimibe

17
Q

What are the main side effects of taking statins?

A

Myopathy and rhabdomyolysis.

Rhabdo can damage the kidneys and cause death.

18
Q

What drugs have the potential to interact with statins and cause an increase in myopathy risk?

A

CYP3A4 inhibitor is the main one.

19
Q

What are fibrates?

What an example of a fibrate that we need to know?

A

Bezafibrate: activates PPARalpha which causes an increase in fatty acid oxidation in muscles and liver plus lipogenesis in the liver.

Increases HDL,

Decreases VLDL, TG and LDL.

20
Q

Explain how you could prevent this from happening?

A

Monoclonal antibody for enzyme which degrades the LDL receptor.